Authors:
Jordan, JH
Walchshofer, S
Jurecka, W
Mosberger, I
Sperr, WR
Wolff, K
Chott, A
Buhring, HJ
Lechner, K
Horny, HP
Valent, P
Citation: Jh. Jordan et al., Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: Evidence for expression of CD2, CD117/Kit, and bcl-x(L), HUMAN PATH, 32(5), 2001, pp. 545-552
Authors:
Schernthaner, GH
Spanblochl, E
Sperr, WR
Sillaber, C
Semper, H
Jurecka, W
Hagen, M
Wolff, K
Chott, A
Lechner, K
Valent, P
Citation: Gh. Schernthaner et al., Effects of interferon-alpha 2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis, ANN HEMATOL, 79(12), 2000, pp. 660-666
Authors:
Blakolmer, K
Vesely, M
Kummer, JA
Jurecka, W
Mannhalter, C
Chott, A
Citation: K. Blakolmer et al., Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas, MOD PATHOL, 13(7), 2000, pp. 766-772
Authors:
Geusau, A
Jurecka, W
Nahavandi, H
Schmidt, JB
Stingl, G
Tschachler, E
Citation: A. Geusau et al., Punctate keratoderma-like lesions on the palms and soles in a patient withchloracne: a new clinical manifestation of dioxin intoxication?, BR J DERM, 143(5), 2000, pp. 1067-1071
Authors:
Schindl, A
Schindl, M
Schindl, L
Jurecka, W
Honigsmann, H
Breier, F
Citation: A. Schindl et al., Increased dermal angiogenesis after low-intensity laser therapy for a chronic radiation ulcer determined by a video measuring system, J AM ACAD D, 40(3), 1999, pp. 481-484